Kimberly Baker, MD
Family Medicine · Cannon Afb, NMNPI 1043693104
Payments from drug & device makers
What this record shows
Merz North America, Inc. accounts for 71.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $2,985 and has fallen 91.7% since, to $249 in 2025. Among family medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $56.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$3K
- AbbVie$609
- Vivus LLC$125
- Novo Nordisk$104
- Amgen$50
- Mindray DS USA, Inc.$48
- plus $126 from 6 others
What the payments were for
- Travel & lodging$1,56242%
- Food & beverage$2,19258%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 13 | $2,692 |
| AbbVie | 34 | $609 |
| Vivus LLC | 1 | $125 |
| Novo Nordisk | 6 | $104 |
| Amgen | 3 | $50 |
| Mindray DS USA, Inc. | 2 | $48 |
| AstraZeneca | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Pfizer | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,754 in reported general payments places this provider in the 95th percentile of 717 family medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 59 | $72,148 |
| OzempicSemaglutide | 28 | $31,182 |
| JardianceEmpagliflozin | 13 | $22,923 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $22,570 |
| JanuviaSitagliptin Phosphate | 24 | $20,740 |
| VraylarCariprazine Hcl | 12 | $20,116 |
| EliquisApixaban | 26 | $17,235 |
| Duloxetine Hcl | 138 | $3,030 |
| SynthroidLevothyroxine Sodium | 31 | $2,790 |
| Doxepin Hcl | 17 | $2,502 |
| Bupropion XlBupropion Hcl | 69 | $2,307 |
| Lisdexamfetamine Dimesylate | 11 | $1,905 |
| Pantoprazole Sodium | 73 | $1,727 |
| Potassium Chloride | 38 | $1,658 |
| Levothyroxine Sodium | 217 | $1,648 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $19 | $72,14859 claims |
| Novo NordiskOzempic | $104 | $31,18228 claims |
| AbbVieVraylar, Synthroid | $609 | $22,90743 claims |
| PfizerEliquis | $15 | $17,23526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 717 family medicine providers in New Mexico.
Other family medicine in Cannon Afb
- Harold McFarlingFarmington$160K
- Carletta BullockAlbuquerque$60K
- Robert BairAlbuquerque$44K
- Wendy JohnsonSanta Fe$37K
- Delliah StamppLas Cruces$21K
- Conchita PazLas Cruces$16K
- Sergio HuertaLas Cruces$11K
- Timothy GrenemyerAlbuquerque$10K
- Cheri BlackstenAlbuquerque$9K
- Brenda CuellarLas Cruces$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.